ZERONDA TYLER (Interim CFO) reported 1 transaction at VYNE THERAPEUTICS INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/4/2023ACC: 0001209191-23-022806
Officer· Interim CFO
Since Jun 2021
-384.00
Net shares
Net seller
$1.2K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
384.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−384.00
Price / share
$3.08
Trade value
$1.18K
% of position
4.5%
3/31/2023
8.49K→8.11K
Total
Net shares
−384.00
Net value
-$1.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/31/2023 | F · Tax Withholding | −384.00 | $3.08 | $1.18K | 4.5% | 8.49K | 8.11K |
| Total | −384.00 | -$1.18K | ||||||
Derivative Transactions0
No derivative transactions reported